Fresenius Medical Care AG & Co. (ADR)  

(Public, NYSE:FMS)   Watch this stock  
Find more results for FMS
49.04
-0.27 (-0.55%)
Jun 23 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 48.93 - 49.39
52 week 38.05 - 50.22
Open 49.12
Vol / Avg. 223,549.00/129,801.00
Mkt cap 29.89B
P/E 22.71
Div/yield 0.53/1.08
EPS 2.16
Shares 306.30M
Beta 0.51
Inst. own 5%

Key stats and ratios

Q1 (Mar '17) 2016
Net profit margin 8.29% 8.65%
Operating margin 14.32% 14.73%
EBITD margin - 18.68%
Return on average assets 5.74% 5.92%
Return on average equity 11.77% 12.01%
Employees 117,000 -
CDP Score - B

Address

Else-Kroener-Strasse 1
BAD HOMBURG, 61352
Germany
+49-6172-6090 (Phone)
+49-6172-6092301 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company's segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment. The Company develops and manufactures a range of dialysis machines, systems and disposable products. As of December 31, 2016, the Company sold its products to customers in more than 120 countries and also used in its internal healthcare service operations. The Company's Care Coordination services include coordinated delivery of pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, health plan services, ambulatory surgery center services and urgent care services.

Officers and directors

Gerd Krick Chairman of the Supervisory Board
Bio & Compensation  - Reuters
Rice Powell Chairman of the Management Board, Chief Executive Officer
Age: 61
Bio & Compensation  - Reuters
Dieter Schenk Vice Chairman of the Supervisory Board
Bio & Compensation  - Reuters
Michael Brosnan Chief Financial Officer, Member of the Management Board
Age: 62
Bio & Compensation  - Reuters
Harry De Wit Chief Executive Officer for Asia-Pacific, Member of the Management Board
Age: 54
Bio & Compensation  - Reuters
Olaf Schermeier Chief Executive Officer for Global Research and Development, Member of the Management Board
Age: 44
Bio & Compensation  - Reuters
William Valle Chief Executive Officer for North America, Member of the Management Board
Age: 56
Bio & Compensation  - Reuters
Kent Wanzek Chief Executive Officer for Global Manufacturing & Quality, Member of the Management Board
Age: 58
Bio & Compensation  - Reuters
Dominik Wehner Chief Executive Officer for Europe, Middle East and Africa (EMEA), Member of the Management Board
Age: 48
Bio & Compensation  - Reuters
Ben J. Lipps Honorary Chairman
Age: 77
Bio & Compensation  - Reuters